Sheryl L Rifas-Shiman1, Abby Fleisch2, Marie-France Hivert3, Christos Mantzoros4, Matthew W Gillman5, Emily Oken6. 1. Obesity Prevention Program, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA. Electronic address: sheryl_rifas@hphc.org. 2. Division of Endocrinology, Boston Children's Hospital, Boston, MA, USA. 3. Obesity Prevention Program, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA. 4. Department of Medicine, Beth Israel Deaconess Hospital, Boston, MA, USA. 5. Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Rockville, MD, USA. 6. Obesity Prevention Program, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Abstract
BACKGROUND: Excessive gestational weight gain (GWG) during pregnancy is associated with adverse outcomes for mothers and offspring. Early, mid, and late pregnancy GWGs have different associations with fetal growth and later life adiposity, but associations with cord blood hormones, which might predict later health, are not well studied. METHODS: In 978 pregnant women from the pre-birth Project Viva cohort, we calculated trimester-specific GWG using clinically recorded prenatal weights. Outcomes were levels of umbilical cord blood hormones related to fetal and postnatal growth. We used linear regression models adjusted for maternal race/ethnicity, pre-pregnancy BMI, parity, education, pregnancy smoking status and child sex; 2nd and 3rd trimester models were additionally adjusted for GWG in prior trimesters. RESULTS: Mean±SD pre-pregnancy BMI was 24.9±5.5kg/m2, 30% were non-white, and 63% were college graduates. Mean±SD cord blood hormone levels were insulin-like growth factor [IGF]-1 (56.4±24.3ng/mL), IGF-2 (408.5±92.7ng/mL), IGFBP-3 (1084±318ng/mL), insulin (6.5±7.2 uU/mL), C-peptide (1.0±0.6ng/mL), leptin (9.0±6.6ng/mL) and adiponectin (28.7±6.8μg/mL). Mean±SD 1st, 2nd and 3rd trimester GWG rates were 0.22±0.22, 0.49±0.19 and 0.46±0.22kg/wk. Greater 1st trimester GWG (per 0.2kg/wk) was associated with higher insulin (0.5 uU/mL; 95% CI 0.1, 0.9) and C-peptide (0.06ng/mL; 95% CI 0.02, 0.09) and lower adiponectin (-0.4μg/mL; 95% CI -0.9, 0.0). Greater 2nd trimester GWG (per 0.2kg/wk) was associated with higher IGF-1 (2.3ng/mL; 95% CI 0.6, 4.0), IGF-2 (7.9ng/mL; 95% CI 1.2, 14.6), IGFBP-3 (41.6ng/mL; 95% CI 19.4, 63.7) and leptin (0.9ng/mL; 0.4, 1.4). 3rd trimester GWG was not associated with cord blood hormones. CONCLUSION: 1st trimester weight gain appears to matter more for cord blood hormones related to offspring glucose/insulin regulation, whereas 2nd trimester gain matters more for hormones related to growth and adiposity.
BACKGROUND:Excessive gestational weight gain (GWG) during pregnancy is associated with adverse outcomes for mothers and offspring. Early, mid, and late pregnancy GWGs have different associations with fetal growth and later life adiposity, but associations with cord blood hormones, which might predict later health, are not well studied. METHODS: In 978 pregnant women from the pre-birth Project Viva cohort, we calculated trimester-specific GWG using clinically recorded prenatal weights. Outcomes were levels of umbilical cord blood hormones related to fetal and postnatal growth. We used linear regression models adjusted for maternal race/ethnicity, pre-pregnancy BMI, parity, education, pregnancy smoking status and child sex; 2nd and 3rd trimester models were additionally adjusted for GWG in prior trimesters. RESULTS: Mean±SD pre-pregnancy BMI was 24.9±5.5kg/m2, 30% were non-white, and 63% were college graduates. Mean±SD cord blood hormone levels were insulin-like growth factor [IGF]-1 (56.4±24.3ng/mL), IGF-2 (408.5±92.7ng/mL), IGFBP-3 (1084±318ng/mL), insulin (6.5±7.2 uU/mL), C-peptide (1.0±0.6ng/mL), leptin (9.0±6.6ng/mL) and adiponectin (28.7±6.8μg/mL). Mean±SD 1st, 2nd and 3rd trimester GWG rates were 0.22±0.22, 0.49±0.19 and 0.46±0.22kg/wk. Greater 1st trimester GWG (per 0.2kg/wk) was associated with higher insulin (0.5 uU/mL; 95% CI 0.1, 0.9) and C-peptide (0.06ng/mL; 95% CI 0.02, 0.09) and lower adiponectin (-0.4μg/mL; 95% CI -0.9, 0.0). Greater 2nd trimester GWG (per 0.2kg/wk) was associated with higher IGF-1 (2.3ng/mL; 95% CI 0.6, 4.0), IGF-2 (7.9ng/mL; 95% CI 1.2, 14.6), IGFBP-3 (41.6ng/mL; 95% CI 19.4, 63.7) and leptin (0.9ng/mL; 0.4, 1.4). 3rd trimester GWG was not associated with cord blood hormones. CONCLUSION: 1st trimester weight gain appears to matter more for cord blood hormones related to offspring glucose/insulin regulation, whereas 2nd trimester gain matters more for hormones related to growth and adiposity.
Authors: Jessica R Walter; Wei Perng; Ken P Kleinman; Sheryl L Rifas-Shiman; Janet W Rich-Edwards; Emily Oken Journal: Am J Obstet Gynecol Date: 2014-11-13 Impact factor: 8.661
Authors: Margaret Parker; Sheryl L Rifas-Shiman; Mandy B Belfort; Elsie M Taveras; Emily Oken; Christos Mantzoros; Matthew W Gillman Journal: J Pediatr Date: 2010-09-19 Impact factor: 4.406
Authors: Christos S Mantzoros; Sheryl L Rifas-Shiman; Catherine J Williams; Jessica L Fargnoli; Theodoros Kelesidis; Matthew W Gillman Journal: Pediatrics Date: 2009-02 Impact factor: 7.124
Authors: Yong Qi; Nobuhiko Takahashi; Stanley M Hileman; Hiralben R Patel; Anders H Berg; Utpal B Pajvani; Philipp E Scherer; Rexford S Ahima Journal: Nat Med Date: 2004-04-11 Impact factor: 53.440
Authors: Nan Li; Tye E Arbuckle; Gina Muckle; Bruce P Lanphear; Michel Boivin; Aimin Chen; Linda Dodds; William D Fraser; Emmanuel Ouellet; Jean R Séguin; Maria P Velez; Kimberly Yolton; Joseph M Braun Journal: Psychoneuroendocrinology Date: 2018-10-25 Impact factor: 4.905
Authors: Andrea L Deierlein; Mary Jo Messito; Michelle Katzow; Lauren Thomas Berube; Cara D Dolin; Rachel S Gross Journal: Pediatr Obes Date: 2019-11-06 Impact factor: 4.000
Authors: Catherine C Cohen; Ellen C Francis; Wei Perng; Katherine A Sauder; Ann Scherzinger; Shikha S Sundaram; Kartik Shankar; Dana Dabelea Journal: Pediatr Obes Date: 2022-02-05 Impact factor: 3.910
Authors: Teresa A Hillier; Keith K Ogasawara; Kathryn L Pedula; Kimberly K Vesco; Caryn E S Oshiro; Jan L Van Marter Journal: J Womens Health (Larchmt) Date: 2020-04-24 Impact factor: 2.681
Authors: Izzuddin M Aris; Sheryl L Rifas-Shiman; Ling-Jun Li; Ken Kleinman; Brent A Coull; Diane R Gold; Marie-France Hivert; Michael S Kramer; Emily Oken Journal: J Pediatr Date: 2018-06-28 Impact factor: 4.406